A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
The EQUIP Center for Learning Health System Science will support researchers working to improve patient safety, particularly among groups that experience persistent health care disparities.
Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Understanding what drives gut stem cells to work nonstop may reveal how idle stem cells elsewhere can be revved up to repair hearts, lungs, and brains. But are scientists studying the right cells?
A novel omega-3 injectable emulsion reduces brain damage in newborn rodents experiencing lack of oxygen at delivery, a major cause of disability in human infants and children.
Researchers at Columbia University College of Dental Medicine have engineered exosomes to carry CRISPR, significantly enhancing the delivery of genome editing components to specific cells and tissues.
A Columbia sociologist makes a case for a sex-positive epidemiology that considers pleasure, satisfaction, and well-being alongside familiar outcomes such as sexually transmitted infections.
Health departments continue to face challenges in recruiting new employees including insufficient funding, a shortage of people with public health training, and lengthy hiring processes.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.